• ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blogs
    • Case Studies
    • Podcasts
    • Webinars
    • White Papers
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Program
  • Contact Us
    • Contact Us
    • Request for Proposal
  • ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blogs
    • Case Studies
    • Podcasts
    • Webinars
    • White Papers
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Program
  • Contact Us
    • Contact Us
    • Request for Proposal
  1. Home
  2. Services
  3. Clinical Pharmacology Modeling Simulation
  4. Model Informed Dose & Drug Development (MIDD)
    • Dose Translation, Rationale, and Justification
    • Bridging and Extrapolation Approaches
    • Modeling and Simulation

Model Informed Dose & Drug Development (MIDD)

  • Clinical Pharmacology Modeling Simulation
  • Clinical Pharmacology Integrated Drug Development
    • Clinical Study Strategy and Design
    • Development and Regulatory Strategy
    • Regulatory Representation, Writing, and Submissions
    • Scientific/Technical Writing, Manuscripts, and Communication
  • Model Informed Dose & Drug Development (MIDD)
    • Dose Translation, Rationale, and Justification
    • Bridging and Extrapolation Approaches
    • Modeling and Simulation
  • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
    • Data Management, Programming, and CDISC Dataset Creation
    • Noncompartmental PK Analysis (NCA)
    • Population Pharmacokinetics (popPK)
  • DMPK and Translational Discovery and Development
    • Drug-Drug Interaction (DDI) Strategy
    • Nonclinical PK, TK, and PD Analyses
    • Nonclinical Strategy, Study Design, and Analysis

With Model-Informed Drug Development (MIDD) existing data can be leveraged to provide important insights on product safety and effectiveness, offering the benefit of more streamlined drug development. Modeling and simulation can help inform decisions that increase the probability of success in clinical studies and reduce the cost of drug development overall. The FDA and EMA have both acknowledged that modeling and simulation is an essential component across all drug development programs involving new molecular entities.

MIDD is useful at any stage of development but is most beneficial when it is integrated early and continuously to help guide program objectives and to make critical decisions. MIDD has the potential to help save large amounts of time, money, and other resources by supporting key program decisions and predicting the likelihood of a drug’s success.

The MIDD paradigm as defined by the most recent FDA guidance states, “MIDD approaches use a variety of quantitative methods to help balance the risks and benefits of drug products in development. When successfully applied, MIDD approaches can improve clinical trial efficiency, increase the probability of regulatory success, and optimize drug dosing/therapeutic individualization in the absence of dedicated trials.”

MIDD Services

It has never been more important to consider utilizing computational MIDD techniques as part of your drug development program. Learn how Allucent can help streamline your drug development program with our Model Informed Dose & Drug Development services including:

  • Dose Translation, Rationale, and Justification
  • Bridging and Extrapolation Approaches
  • Modeling and Simulation

Contact Us

Let us partner with your team on bringing new therapies to light. Get in touch to get started.

CONTACT US

  • Services
    • Clinical Trial Operations
    • Regulatory and Drug Development Consulting
    • Government and Public Health Services
    • Biometrics
    • Clinical Pharmacology Modeling Simulation
  • Therapeutic Expertise
    • Oncology and Hematology
    • Rare Diseases and Orphan Drugs
    • Infectious Disease and Vaccine
    • Cell and Gene Therapy
    • Central Nervous System
    • Autoimmune and Inflammation
    • Allergy and Asthma
  • Company
    • About Us
    • News
    • Events
  • Privacy Policy
  • English
  • Francais

© 2023 Allucent. All rights

North American Headquarters
2000 Centregreen Way
Suite 300
Cary, North Carolina 27513
+1 919-361-2286

United Kingdom Headquarters
1st Floor, One Station Square,
Bracknell, Berkshire
RG12 1QB United Kingdom
T: +44 (0) 1344 891121
F: +44 (0) 1344 890335

European Headquarters
Stationsplein Noord-Oost 438
1117 CL Schiphol
The Netherlands
+31 20-4350-580